Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability

Atherosclerosis is a continuous pathological process that starts early in life and progresses frequently to unstable plaques. Plaque rupture leads to deleterious consequences such as acute coronary syndrome, stroke and atherothrombosis. The vulnerable lesion has several structural and functional hallmarks that distinguish it from the stable plaque. The unstable plaque has large necrotic core (over 40% plaque volume) composed of cholesterol crystals, cholesterol esters, oxidized lipids, fibrin, erythrocytes and their remnants (haeme, iron, haemoglobin), and dying macrophages. The fibrous cap is thin, depleted of smooth muscle cells and collagen, and is infiltrated with proinflammatory cells. In unstable lesion, formation of neomicrovessels is increased. These neovessels have weak integrity and leak thereby leading to recurrent haemorrhages. Haemorrhages deliver erythrocytes to the necrotic core where they degrade promoting inflammation and oxidative stress. Inflammatory cells mostly presented by monocytes/macrophages, neutrophils and mast cells extravagate from bleeding neovessels and infiltrate adventitia where they support chronic inflammation. Plaque destabilization is an evolutionary process that could start at early atherosclerotic stages and whose progression is influenced by many factors including neovascularization, intraplaque haemorrhages, formation of cholesterol crystals, inflammation, oxidative stress and intraplaque protease activity.

[1]  M. Goumans,et al.  Balance between Angiopoietin-1 and Angiopoietin-2 Is in Favor of Angiopoietin-2 in Atherosclerotic Plaques with High Microvessel Density , 2008, Journal of Vascular Research.

[2]  H. Zentgraf,et al.  Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin , 2007, Cell Death and Differentiation.

[3]  Paul Schoenhagen,et al.  Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process. , 2002, Circulation.

[4]  J. Eaton,et al.  Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  P. Kovanen,et al.  Cholesterol crystals activate the NLRP3 inflammasome in human monocytes and macrophages , 2010 .

[6]  R. Virmani,et al.  Free cholesterol in atherosclerotic plaques: where does it come from? , 2007, Current opinion in lipidology.

[7]  Q. Gao,et al.  Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice , 2013, Cellular and Molecular Immunology.

[8]  David Zurakowski,et al.  Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  O. Wiklund,et al.  Evidence of hypoxic areas within the arterial wall in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[10]  I. Loftus,et al.  High Levels of Costimulatory Receptors OX40 and 4-1BB Characterize CD4+CD28null T Cells in Patients With Acute Coronary Syndrome , 2012, Circulation research.

[11]  Mark M. Kockx,et al.  Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[12]  R. Virmani,et al.  Concept of vulnerable/unstable plaque. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[13]  A. Levy,et al.  Haptoglobin: basic and clinical aspects. , 2010, Antioxidants & redox signaling.

[14]  P. Kovanen,et al.  Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid. , 2001, Atherosclerosis.

[15]  J. Paramo,et al.  Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL. , 2004, Cardiovascular research.

[16]  R. Dean,et al.  Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. , 2000, Journal of lipid research.

[17]  W. J. Johnson,et al.  Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. , 1994, Journal of lipid research.

[18]  Yun Zhang,et al.  Haemin‐enhanced expression of haem oxygenase‐1 stabilizes erythrocyte‐induced vulnerable atherosclerotic plaques , 2010, British journal of pharmacology.

[19]  A. Levy,et al.  Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E , 2007, Expert review of cardiovascular therapy.

[20]  Jian-Xiong Chen,et al.  Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Alexis Lama T,et al.  [Statins in acute coronary syndrome]. , 2008, Revista medica de Chile.

[22]  R. Kurzrock,et al.  Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target? , 2010, The oncologist.

[23]  Jack Rubinstein,et al.  The impact of circulating cholesterol crystals on vasomotor function: implications for no-reflow phenomenon. , 2011, JACC. Cardiovascular interventions.

[24]  P. Kovanen,et al.  Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. , 1996, The Journal of clinical investigation.

[25]  P. E. Van den Steen,et al.  Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.

[26]  X. Puente,et al.  LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity , 2007, PloS one.

[27]  L. R. Padial,et al.  A Proteomic Focus on the Alterations Occurring at the Human Atherosclerotic Coronary Intima* , 2011, Molecular & Cellular Proteomics.

[28]  Jason L. Johnson,et al.  Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability , 2007, Expert review of cardiovascular therapy.

[29]  D. Bergqvist,et al.  Intraplaque haemorrhage at carotid artery surgery ‐ a predictor of cardiovascular mortality , 1995, Journal of Internal Medicine.

[30]  M. Soares,et al.  Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin , 2013, Oxidative medicine and cellular longevity.

[31]  Helen X. Chen,et al.  Adverse effects of anticancer agents that target the VEGF pathway , 2009, Nature Reviews Clinical Oncology.

[32]  M. Mulligan-Kehoe The vasa vasorum in diseased and nondiseased arteries. , 2010, American Journal of Physiology. Heart and Circulatory Physiology.

[33]  M. Gerritsen,et al.  Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Moll,et al.  Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: a histopathological study in carotid plaques. , 2012, Atherosclerosis.

[35]  E. Ritman,et al.  Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. , 2004, Journal of the American Society of Nephrology : JASN.

[36]  S. Fukumoto,et al.  Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells , 2000 .

[37]  T. Akasaka,et al.  Assessment of coronary atherosclerosis using optical coherence tomography. , 2014, Journal of atherosclerosis and thrombosis.

[38]  I. Tentes,et al.  Statin Use is Associated with a Significant Reduction in Cholesterol Content of Erythrocyte Membranes. A Novel Pleiotropic Effect? , 2009, Cardiovascular Drugs and Therapy.

[39]  G. Franceschini,et al.  Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[40]  K. Aziz,et al.  Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events--a novel insight into plaque rupture by scanning electron microscopy. , 2006, Scanning.

[41]  E. Raines,et al.  Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. , 2005, The Journal of clinical investigation.

[42]  R. Frye,et al.  Interleukin 12 Induces T-Cell Recruitment Into the Atherosclerotic Plaque , 2006, Circulation research.

[43]  J. Eaton,et al.  Heme, heme oxygenase and ferritin in vascular endothelial cell injury. , 2005, Molecular nutrition & food research.

[44]  R. Califf,et al.  Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study , 2001, The Lancet.

[45]  S. Kaul,et al.  Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. , 1999, Circulation.

[46]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[47]  F. Altruda,et al.  Hemopexin: structure, function, and regulation. , 2002, DNA and cell biology.

[48]  W. Liles,et al.  The phagocytes: neutrophils and monocytes. , 2008, Blood.

[49]  A. Levy,et al.  The genetics of vascular complications in diabetes mellitus. , 2010, Cardiology clinics.

[50]  J. Alam,et al.  Heme-hemopexin-mediated induction of metallothionein gene expression. , 1992, The Journal of biological chemistry.

[51]  S. Gabriel,et al.  B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[52]  J. Stark,et al.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. , 2009, The American journal of pathology.

[53]  W. Shimizu,et al.  Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study , 2014, Clinical Research in Cardiology.

[54]  P. Kovanen,et al.  Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture , 2004, Current opinion in lipidology.

[55]  V. Hasselblad,et al.  Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status: The PARAGON-B Troponin T Substudy , 2001, Circulation.

[56]  Claudio Napoli,et al.  Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia , 2004, Circulation.

[57]  R. Virmani,et al.  Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. , 2012, Journal of the American College of Cardiology.

[58]  P. Libby,et al.  Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.

[59]  G. Liuzzo Unusual CD4 CD28 T Lymphocytes and Recurrence of Acute Coronary Events , 2007 .

[60]  R. Goldbach-Mansky,et al.  IL-1 blockade in autoinflammatory syndromes. , 2014, Annual review of medicine.

[61]  M. Bäck,et al.  The Role of Matrix Metalloproteinases in Atherothrombosis , 2011, Current atherosclerosis reports.

[62]  C. Alpers,et al.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.

[63]  P. Serruys,et al.  Coronary stents: historical development, current status and future directions. , 2013, British medical bulletin.

[64]  M. Chiariello,et al.  Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque: Evidence for a Local, Intracoronary Immunologic Mechanism , 2006, Circulation.

[65]  E. Ritman,et al.  Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia--implications for vulnerable plaque-development. , 2007, Atherosclerosis.

[66]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[67]  A. Meyrier Cholesterol crystal embolism: diagnosis and treatment. , 2006, Kidney international.

[68]  K. Kanmatsuse,et al.  [Pathogenesis of acute coronary syndromes]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[69]  D. Böckler,et al.  The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. , 2013, International journal of molecular medicine.

[70]  M. Mayr,et al.  The paradox of hypoxic and oxidative stress in atherosclerosis. , 2008, Journal of the American College of Cardiology.

[71]  D. Woolley,et al.  Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. , 1994, European journal of biochemistry.

[72]  Z. Motovska,et al.  Stent thrombosis--risk assessment and prevention. , 2010, Cardiovascular therapeutics.

[73]  P. Harrison,et al.  Structure, function, and evolution of ferritins. , 1992, Journal of inorganic biochemistry.

[74]  D. Agrawal,et al.  MMP‐1 and MMP‐9 regulate epidermal growth factor‐dependent collagen loss in human carotid plaque smooth muscle cells , 2014, Physiological reports.

[75]  P. Libby,et al.  An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro , 2001, Circulation.

[76]  J. Eaton,et al.  Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. , 2007, Antioxidants & redox signaling.

[77]  J. Michel,et al.  Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment , 2007, Journal of leukocyte biology.

[78]  P. Douek,et al.  In Vivo Magnetic Resonance Imaging of Large Spontaneous Aortic Aneurysms in Old Apolipoprotein E-Deficient Mice , 2004, Investigative radiology.

[79]  P. Escribá,et al.  Regulation of heme oxygenase and metallothionein gene expression by the heme analogs, cobalt-, and tin-protoporphyrin. , 1993, The Journal of biological chemistry.

[80]  Yong Chen,et al.  The Th17/Treg imbalance in patients with acute coronary syndrome. , 2008, Clinical immunology.

[81]  N. Shaklai,et al.  Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines. , 1994, Biochemistry and molecular biology international.

[82]  Yoon K Loke,et al.  Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. , 2007, JAMA.

[83]  P. Carmeliet,et al.  Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. , 2010, Cardiovascular research.

[84]  E L Ritman,et al.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.

[85]  Chun Yuan,et al.  Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.

[86]  Renu Virmani,et al.  Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. , 2009, Journal of the American College of Cardiology.

[87]  E. Ritman,et al.  Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular research.

[88]  G. Doronzo,et al.  C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. , 2005, The Journal of laboratory and clinical medicine.

[89]  P. Heeringa,et al.  Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. , 2001, The American journal of pathology.

[90]  A. Naylor,et al.  Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. , 2007, Journal of vascular surgery.

[91]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[92]  J. Kassirer Atheroembolic renal disease. , 1969, The New England journal of medicine.

[93]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[94]  B. Roelofsen,et al.  Kinetics and site specificity of hydroperoxide-induced oxidative damage in red blood cells. , 1992, Free radical biology & medicine.

[95]  R. de Caterina,et al.  Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. , 2010, Cardiovascular research.

[96]  C. Vahl,et al.  Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima , 2008, Thrombosis and Haemostasis.

[97]  M. Shintaku,et al.  Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. , 2007, Journal of atherosclerosis and thrombosis.

[98]  Mathijs Groeneweg,et al.  Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. , 2008, Journal of the American College of Cardiology.

[99]  A. Maseri,et al.  Expansion of T-Cell Receptor &zgr;dim Effector T Cells in Acute Coronary Syndromes , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[100]  A. Newby,et al.  Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[101]  K. Matsubara,et al.  Phosphatidylcholine hydroperoxide promotes VEGF-induced angiogenesis in endothelial cells and rat aorta ring cultures. , 2011, Biochimica et biophysica acta.

[102]  Michael E. Hall,et al.  Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. , 2013, Physiology.

[103]  A. Orekhov,et al.  Vascular Extracellular Matrix in Atherosclerosis , 2013, Cardiology in review.

[104]  Y. L. Chen,et al.  Increased ferritin gene expression in atherosclerotic lesions. , 1996, The Journal of clinical investigation.

[105]  S. Husson,et al.  Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. , 2003, European journal of biochemistry.

[106]  J. Michel,et al.  From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages , 2012, Journal of cardiovascular medicine.

[107]  V. Fuster,et al.  Macrophages Transmit Potent Proangiogenic Effects of oxLDL In Vitro and In Vivo Involving HIF-1α Activation: a Novel Aspect of Angiogenesis in Atherosclerosis , 2013, Journal of Cardiovascular Translational Research.

[108]  X. Filella,et al.  Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients , 2006, Scandinavian journal of clinical and laboratory investigation.

[109]  J. Jukema,et al.  Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[110]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[111]  K. Varani,et al.  Adenosine Modulates HIF-1&agr;, VEGF, IL-8, and Foam Cell Formation in a Human Model of Hypoxic Foam Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[112]  J. Fernandes,et al.  Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis. , 2013, Cellular immunology.

[113]  K. Aziz,et al.  Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. , 2009, The American journal of cardiology.

[114]  P. Libby,et al.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[115]  B. Kou,et al.  Effects of cyclic strain on endothelial cell apoptosis and tubulogenesis are dependent on ROS production via NAD(P)H subunit p22phox. , 2009, Microvascular research.

[116]  S. Fukumoto,et al.  Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. , 2000, Biochemical and biophysical research communications.

[117]  K. Berger,et al.  Plaque Rupture and Thrombosis Are Reduced by Lowering Cholesterol Levels and Crystallization With Ezetimibe and Are Correlated With Fluorodeoxyglucose Positron Emission Tomography , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[118]  J. Boyle Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage , 2012, Current opinion in lipidology.

[119]  J. Michel,et al.  The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells , 2007, The Journal of pathology.

[120]  J. Eaton,et al.  Red Cells, Hemoglobin, Heme, Iron, and Atherogenesis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[121]  F. Moll,et al.  High Neutrophil Numbers in Human Carotid Atherosclerotic Plaques Are Associated With Characteristics of Rupture-Prone Lesions , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[122]  S. Weiss,et al.  Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Chunhong Ma,et al.  IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. , 2011, Clinical immunology.

[124]  A. Dembińska-kieć,et al.  Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages. , 2000, Acta biochimica Polonica.

[125]  G. Biondi-Zoccai,et al.  Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). , 2010, The American journal of cardiology.

[126]  Antonius F. W. van der Steen,et al.  Molecular imaging of inflammation and intraplaque vasa vasorum: A step forward to identification of vulnerable plaques? , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[127]  Jean-Baptiste Michel,et al.  Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[128]  K. Moulton Angiogenesis in atherosclerosis: gathering evidence beyond speculation , 2006, Current opinion in lipidology.

[129]  J. Burke,et al.  Statins alter neutrophil migration by modulating cellular Rho activity—a potential mechanism for statins‐mediated pleotropic effects? , 2008, Journal of leukocyte biology.

[130]  Toshihiro Kobayashi,et al.  Neutrophil infiltration and oxidant-production in human atherosclerotic carotid plaques. , 2011, Histology and histopathology.

[131]  F. Sellke,et al.  High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction Without Improving the Angiogenic Response , 2006, Circulation.

[132]  柚木 佳 Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes , 2011 .

[133]  Wouter Peeters,et al.  Composition of Carotid Atherosclerotic Plaque Is Associated With Cardiovascular Outcome: A Prognostic Study , 2010, Circulation.

[134]  R. de Leeuw,et al.  Nonsteroidal anti-inflammatory drugs and antihypertensives: how do they relate? , 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

[135]  Huixia Lu,et al.  Pathological mechanisms of erythrocyte-induced vulnerability of atherosclerotic plaques. , 2008, Medical hypotheses.

[136]  A. Balbarini,et al.  Angiogenesis as risk factor for plaque vulnerability. , 2009, Current pharmaceutical design.

[137]  E. Ritman,et al.  Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis. , 2009, Atherosclerosis.

[138]  P. Kovanen Mast cells: multipotent local effector cells in atherothrombosis , 2007, Immunological reviews.

[139]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[140]  F. Crea,et al.  Anti-inflammatory treatment of acute coronary syndromes. , 2011, Current pharmaceutical design.

[141]  G. Bergström,et al.  Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques. , 2010, Biochemical and biophysical research communications.

[142]  R. Frye,et al.  T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes , 2002, Circulation.

[143]  K. Walsh,et al.  Statin therapy and angiogenesis , 2003, Current opinion in lipidology.

[144]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[145]  Y. Bobryshev,et al.  Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. , 1999, Cardiovascular research.

[146]  A. Rebuzzi,et al.  Unusual CD4+CD28nullT Lymphocytes and Recurrence of Acute Coronary Events , 2007 .

[147]  Kayoko Sato,et al.  T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome , 2006, Circulation research.

[148]  I. Mitroulis,et al.  Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome. , 2010, European journal of internal medicine.

[149]  G. Biondi-Zoccai,et al.  Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. , 2013, The American journal of cardiology.

[150]  J. Aschner,et al.  Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model. , 2012, American journal of physiology. Heart and circulatory physiology.

[151]  E. Ritman,et al.  Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering , 2002, Circulation.

[152]  Juan J. Badimon,et al.  Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.

[153]  Gieri Cathomas,et al.  Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.

[154]  L. Lerman,et al.  Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia , 2009, Basic Research in Cardiology.

[155]  V. Fuster,et al.  Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. , 1995, Circulation.

[156]  Huixia Lu,et al.  Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. , 2007, Journal of molecular and cellular cardiology.

[157]  Qingbo Xu,et al.  Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes , 2004, Circulation.

[158]  T. Paavonen,et al.  Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. , 1999, Circulation.

[159]  J. Kaski,et al.  CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. , 2009, Cardiovascular research.

[160]  Ruiping Huang,et al.  Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. , 2011, The American journal of cardiology.

[161]  Qingbo Xu,et al.  Heat-Shock Protein 60 – Reactive CD 4 CD 28 null T Cells in Patients With Acute Coronary Syndromes , 2004 .

[162]  Jean-Baptiste Michel,et al.  Intraplaque haemorrhages as the trigger of plaque vulnerability , 2011, European heart journal.

[163]  F. Loffredo,et al.  C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture. , 2013, International journal of cardiology.

[164]  J. Yodoi,et al.  Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage. , 2008, Atherosclerosis.

[165]  J. Waltenberger,et al.  High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine: relevance to the human situation? , 2007, The Journal of thoracic and cardiovascular surgery.

[166]  R. Frye,et al.  Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.

[167]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[168]  P R Bell,et al.  Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.

[169]  M. Gilard,et al.  Surgical angioplasty with exclusion of atheromatous plaques in case of diffuse disease of the left anterior descending artery: 2 years' follow-up. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[170]  Chao Zhang,et al.  Relationship between Enhanced Intensity of Contrast Enhanced Ultrasound and Microvessel Density of Aortic Atherosclerostic Plaque in Rabbit Model , 2014, PloS one.

[171]  J. Montero,et al.  Intravitreal inserts of steroids to treat diabetic macular edema. , 2009, Current diabetes reviews.